Insurers said they had to withdraw coverage because the pricey medicines overwhelmed their budgets, forcing patients to either go off the drugs or pay for them out of pocket.
Researchers at Eli Lilly and others published a phase II trial this week that combined semaglutide, the active ingredient in ...
Feeling less than confident about your weekly miles? We help you find your right training approach.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results